Schering Stiftung

Prize winner 

Dr. med. Stefan Uderhardt

Dr. med. Stefan Uderhardt

Stefan Uderhardt

Avrion Mitchison Prize 2012

Dr. med. Stefan Uderhardt

Stefan Uderhardt

Avrion Mitchison Prize 2012


Dr. Stefan Uderhardt is the recipient of the 2012 Avrion Mitchison Prize for Rheumatology for his work, “12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance.”

Uderhardt, born in 1984, studied medicine at the University of Erlangen-Nuremberg from 2004 until 2010. From 2008 until 2011, he worked on his dissertation in the lab of Dr. Gerhard Krönke at the Institute for Rheumatology and Clinical Immunology at the University’s Medical Clinic 3, writing his thesis on the “Molecular Regulation of Bone Remodeling in Inflammatory Arthritis.” Since 2010, he has been a resident physician and research associate at the Medical Clinic 3.

At the award ceremony, Dr. Stefan Uderhardt will present his current research, “12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance”.

“One major task of the immune system is to efficiently eliminate invading pathogens and to maintain immunological self-tolerance at the same time. However, during inflammation and consequent tissue damage, the innate immune system is challenged with both pathogens and dying cells. Defective clearance of apoptotic cells has emerged as a crucial factor in the development of autoimmune diseases. The ingestion and processing of self-antigens derived from apoptotic cells by inflammatory antigen-presenting cells could provoke an unwanted immune response and could result in a break of self-tolerance leading to autoimmunity. Therefore, there must be mechanisms, especially under inflammatory conditions, which regulate a selective cellular sorting of different antigens into differentially-activated phagocyte compartments.

We have identified the lipid-oxidizing enzyme 12/15-lipoxygenase (12/15-LO) as a crucial factor orchestrating the non-inflammatory clearance of apoptotic cells under inflammatory conditions. During inflammation, the uptake of apoptotic cells was strictly confined to a population of alternatively-activated, 12/15-LO-expressing, resident tissue macrophages. Pathogens like bacteria, on the other hand, were mainly taken up into freshly recruited inflammatory phagocytes. Here, resident macrophages could actively block the uptake of apoptotic cells into inflammatory macrophages in a 12/15-LO-dependend manner. By exposing 12/15-LO-generated oxidation-products of phosphatidylethanolamin (PE) on the surface of their cell membranes, resident macrophages could eliminate distinct soluble receptors for apoptotic cells such as the milk fat globule-EGF factor 8 (MFGE8), which was utilized by inflammatory phagocytes to take up apoptotic cells. Mass-spectrometry data revealed that specific PE oxidation products were absent in resident macrophages from 12/15-LO knockout mice. 12/15-LO-deficiency, in turn, caused an aberrant uptake of apoptotic cells with a clear shift towards inflammatory macrophages and subsequent presentation of AC-derived self-antigen in vitro and in vivo, respectively. Indeed, we could observe a break of self-tolerance and a lupus-like autoimmune disease in aged 12/15-LO-deficient mice. These mice showed a spontaneous production of autoantibodies and development of glomerulonephritis, both hallmarks of autoimmune diseases like human Systemic Lupus Erythematosus. This phenotype even exacerbated after apoptotic challenge in the Pristane-induced model of experimental murine lupus.

Our data point towards a so far unrecognized role for enzymatic lipid oxidation during the maintenance of self-tolerance and uncovered a mechanism by which the selective uptake of antigens of different origins into differentially activated phagocyte subsets is orchestrated in a cell- and context-specific manner.”

Read more

Side events 

Award Ceremony

December 04, 2012, 5–7:30 p.m.
Avrion-Mitchison-Prize for Rheumatology 2012 and Albrecht-Hasinger-Lecture 2012

Foyer des Deutschen Rheuma-Forschungszentrums Berlin
Campus Charité Mitte | Charitéplatz 1 | 10117 Berlin

DRFZ Website

Albrecht-Hasinger-Lecture 2012 

Lecture — December 04, 2012

On December 4th, 2012 at 6.10 p.m. the Albrecht Hasinger Lecture is hold by Prof. Mark J. Shlomchik from Yale University School of Medicine on “Lupus Pathogenesis: B vs. DC and Other NET Results”.

Learn more

You might also be interested in

December 05, 2017

Rafael Leite Dantas

Avrion Mitchison Prize 2017

December 04, 2018

Quirin Sebastian Hammer

Avrion Mitchison Prize 2018

December 06, 2016

Corinna Wehmeyer

Avrion Mitchison Prize 2016

December 01, 2015

Caroline von Spee-Mayer and Christian Neumann

Avrion Mitchison Prize 2015

December 02, 2014

Christine Schauer

Avrion Mitchison Prize 2014

December 03, 2013

Dirk Baumjohann

Avrion Mitchison Prize 2013

Newsletter 

Contact & social networks

Schering Stiftung

Unter den Linden 32-34
10117 Berlin

Telefon: +49 - 30 - 20 62 29 65
Email: info@scheringstiftung.de

Opening hours
Project space

Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm
free entrance

Follow us!

Follow us on our social media channels to find out the latest developments!

facebook Youtube Instagram